Startsida
Hjälp
Sök i LIBRIS databas

     

 

Sökning: onr:n17p9ln1lxl6qs9v > Effect of targeted ...

Effect of targeted vs standard fortification of breast milk on growth and development of preterm infants (<= 32weeks) [Elektronisk resurs] study protocol for a randomized controlled trial

Seliga-Siwecka, Joanna (författare)
Chmielewska, Anna (författare)
Jasinska, Katarzyna (författare)
Umeå universitet Medicinska fakulteten (utgivare)
Publicerad: BioMed Central, 2020
Engelska.
Ingår i: Trials. - 1745-6215. ; 21:1
Läs hela texten
Läs hela texten
Läs hela texten
  • E-artikel/E-kapitel
Sammanfattning Ämnesord
Stäng  
  • Background: Human milk is recommended for all very low birth weight infants. Breastmilk is highly variable in nutrient content, failing to meet the nutritional demands of this group. Fortification of human milk is recommended to prevent extrauterine growth retardation and associated poor neurodevelopmental outcome. However, standard fortification with fixed dose multicomponent fortifier does not account for the variability in milk composition. Targeted fortification is a promising alternative and needs further investigation. Methods: This randomized controlled trial will recruit preterm infants (≤ 32 weeks of gestation) within the first 7 days of life. After reaching 80 ml/kg/day of enteral feeding, patients will be randomized to receive standard fortification (HMF, Nutricia) or targeted fortification (modular components: Bebilon Bialka, Nutricia—protein; Polycal, Nutricia—carbohydrates; Calogen, Nutricia—lipids). The intervention will continue until 37 weeks of post-conception age or hospital discharge. Parents and outcome assessors will be blinded to the intervention. The primary outcome measure is velocity of weight, length, and head growth until 36 weeks post-conceptional age or discharge. Secondary outcomes include neurodevelopment at 12 months assessed with Bayley Scale of Development III, repeated at 36 months; body composition at discharge and at 4 months; and incidence of necrotizing enterocolitis, sepsis, retinopathy of prematurity, and bronchopulmonary dysplasia. Discussion: Targeted fortification has previously been shown as doable in the neonatal intensive care unit context. If it shows to improve growth and neonatal outcome, choosing the targeted fortification as a first line nutritional approach in very low birth weight infants may become a recommendation. Trial registration: ClinicalTrials.govNCT03775785, Registered on July 2019. 

Ämnesord

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Pediatrics  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Pediatrik  (hsv)

Genre

government publication  (marcgt)

Indexterm och SAB-rubrik

Preterm
Very low birth weight
Enteral nutrition
Breast milk
Fortification
Growth
Inställningar Hjälp

Ingår i annan publikation. Gå till titeln Trials

Om LIBRIS
Sekretess
Hjälp
Fel i posten?
Kontakt
Teknik och format
Sök utifrån
Sökrutor
Plug-ins
Bookmarklet
Anpassa
Textstorlek
Kontrast
Vyer
LIBRIS söktjänster
SwePub
Uppsök

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy